Answers are grounded in this paper and cite their sources.
Early intervention with lenalidomide in smoldering multiple myeloma significantly delays progression to symptomatic multiple myeloma and the development of end-organ damage.
No takes yet. Share an insight, caveat, or question.
Lonial et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: